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Available online 1 June 2017Polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) are environmental pollutants
that produce neurotoxicity and neuroendocrine disruption. They affect the vasopressinergic system but their dis-
ruptive mechanisms are not well understood. Our group reported that rats perinatally exposed to Aroclor-1254
(A1254) and DE-71 (commercial mixtures of PCBs and PBDEs) decrease somatodendritic vasopressin (AVP) re-
lease while increasing plasma AVP responses to osmotic activation, potentially emptying AVP reserves required
for body-water balance. The aim of this researchwas to evaluate the effects of perinatal exposure to A1254 or DE-
71 (30mg kg/day) on AVP transcription and protein content in the paraventricular and supraoptic hypothalamic
nuclei, of male and female rats, by in situ hybridization and immunohistochemistry. cFOSmRNA expression was
evaluated in order to determine neuroendocrine cells activation due to osmotic stimulation. Animal groupswere:
vehicle (control); exposed to either A1254 or DE-71; both, control and exposed, subjected to osmotic challenge.
The results conﬁrmed a physiological increase in AVP-immunoreactivity (AVP-IR) and gene expression in re-
sponse to osmotic challenge as reported elsewhere. In contrast, the exposed groups did not show this response
to osmotic activation, they showed signiﬁcant reduction in AVP-IR neurons, and AVP mRNA expression as com-
pared to the hyperosmotic controls. cFOS mRNA expression increased in A1254 dehydrated groups, suggesting
that the AVP-IR decrease was not due to a lack of the response to the osmotic activation. Therefore, A1254
may interfere with the activation of AVP mRNA transcript levels and protein, causing a central dysfunction of
vasopressinergic system.
© 2017 Elsevier Inc. All rights reserved.Keywords:
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The maintenance of water homeostasis is vital for living beings. The
neuropeptides secreted by the hypothalamic-neurohypophysial sys-
tem, vasopressin (AVP) and oxytocin (OXT), play key roles in homeosta-
sis and ﬁne-tuning of osmotic regulation (Bourque, 2008; Schrier and
Martin, 1998; Weitzman and Kleeman, 1979). These neuropeptides
exert a wide range of actions and control not only uponwater and sodi-
um excretion by the kidneys, they also inﬂuence cardiovascular
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productive behavior and stress-related responses, among others
(Cunningham and Sawchenko, 1991; Pittman and Bagdan, 1992;
Riphagen and Pittman, 1986; Neumann and Landgraf, 2012; Witt,
1995). Osmotic and volume stimuli, such as dehydration and hemor-
rhage, activate magnocellular neuroendocrine cells (MNCs) in the
paraventricular (PVN) and supraoptic nuclei (SON) of the hypothala-
mus. In response to this activation, MNCs produce both AVP and OXT
that are released into the systemic circulation from axon terminals lo-
cated in the neurohypophysis and within the PVN and the SON from
soma and dendrites (somatodendritic release) (Hatton et al., 1978;
Ludwig and Leng, 1998; Ludwig et al., 1994). Somatodendritic AVP ex-
erts autoinhibitory control over plasma AVP hormonal output. There-
fore, the central and peripheral AVP are essential to maintain
osmoregulation (Ludwig and Leng, 1998; Riphagen and Pittman,
1986; Wotjak et al., 1994).
It has been well established that a wide variety of environmental
pollutants have speciﬁc effects on the neuroendocrine systems of mam-
mals, therefore, the concept of neuroendocrine disruptors was devel-
oped (Leon-Olea et al., 2014; Currás-Collazo, 2011; Waye and
Trudeau, 2011). Industrial organohalogens such as polychlorinated bi-
phenyls (PCBs) and polybrominated diphenyl ethers (PBDEs), widely
used as ﬂame retardants, are neurotoxic agents and neuroendocrine
disruptors that pollute outdoor and indoor environments (de Wit et
al., 2012; Birnbaum and Staskal, 2004). They are lipophilic and
bioaccumulate in wildlife and humans (de Wit, 2002; Kodavanti et al.,
1998; Tilson et al., 1998). After two accidental contamination incidents
that lead to death and several adverse health effects in humans, PCBs
were banned from production in 1977 but still linger in human tissues
and the environment (Lang, 1992; Mariussen and Fonnum, 2006; Safe,
1993; Wu et al., 2011). PBDEs are similar in structure to PCBs but the
bromide radical substitutes for chloride (Covaci et al., 2011; Wiseman
et al., 2011). The current commercial formulation of PBDEs is decaBDE
(10 bromines). PentaBDE and octaBDE (5, 8 bromines respectively)
were voluntarily withdrawn from the market in 2004 (U.S.
Environmental Protection Agency, USEPA, 2010). These pollutants, as
the PCBs, are added to household appliances, furniture, textiles, plastics,
electronic devices and packaging materials, thus it is a major source of
the indoor pollution that affects humans, especially infants and toddlers
(Birnbaum and Staskal, 2004; deWit et al., 2012). PCBs and PBDEs have
been detected in human blood, adipose tissue, and they cross through
the placental barrier and in to breast milk (Jacobson et al., 1984;
Kodavanti et al., 1998; Takagi et al., 1986). They disrupt brain develop-
ment, learning and memory, and the reproductive and endocrine sys-
tems via alterations in thyroid, growth, and reproductive hormones
(Chung et al., 2001; Hamers et al., 2006; Kodavanti et al., 2010;
Kodavanti and Curras-Collazo, 2010; Ness et al., 1993; Steinberg et al.,
2007; Viberg et al., 2006). The effects of these organohalogens depend
on factors such as dosage, sex, susceptibility of each organism, type of
congener, duration of exposure, physiological activation, and life stage
at which the organism is exposed (Faroon et al., 2001; McKinney and
Waller, 1994; Viberg et al., 2006). PCBs and PBDEs produce neurotoxic-
ity by disrupting protein kinase C (PKC) and perturbing intracellular cal-
cium homeostasis, nitric oxide signaling, neurotransmitter release,
synaptic plasticity, gene expression, oxidative stress, and energymetab-
olism in the brain (Coburn et al., 2008, 2015; Kodavanti et al., 2011;
Royland and Kodavanti, 2008; Tilson et al., 1998; Westerink, 2014;
Wong et al., 1997).
Organohalogens also disrupt the vasopressinergic system (Coburn et
al., 2007; Coburn et al., 2005; Kodavanti and Curras-Collazo, 2010). We
have previously reported that exposure to Aroclor 1254 (A1254) and
DE-71, commercial mixtures of PCBs and PBDEs respectively, increases
plasma vasopressin release, and decrease somatodendritic AVP release
during hyperosmotic stimulation in adult rats, suggesting that PCBs
and PBDEs could disrupt signalingmechanisms required for AVP release
in response to an osmotic stimulus (Coburn et al., 2007; Coburn et al.,2005). Moreover, perinatal exposure to PBDEs alters AVP-related func-
tions, producing exaggerated cardiovascular reactivity and compro-
mised osmoregulatory capacity in late-adulthood rats (Shah et al.,
2011). The mechanisms by which PCBs and PBDEs disrupt the
vasopressinergic system remain unknown. Based on our previous re-
port showing elevated plasma and reduced somatodendritic vasopres-
sin in response to these pollutants, we hypothesize that these
organohalogens may disrupt the AVP transcription and/or protein con-
tent in the PVN and SON cells populations in rats with prolonged or
acute hyperosmotic challenge. Therefore, the aim of this research was
to elucidate the effects of perinatal exposure to either A1254 or DE-71
(30 mg kg/day) on AVP gene and protein responses to osmotic stimula-
tion in the rat PVN and SON hypothalamic nuclei.
2. Materials and methods
2.1. Animals
The experimental animals were maintained under controlled labo-
ratory conditionswith a light-dark (12:12 h) cycle and ad libitum access
to water and a regular diet (commercial pellets Lab Chow 5001 Purina
USA). A group of time-pregnant Wistar rats on gestational day (GD)
two (based on a GD 0, as the day of insemination, indicated by copula-
tory plug)was obtained from the animal care facility of INPRFM,México
(cohort I and cohort III). In parallel, a group of timed-pregnant Sprague-
Dawley (SD) rats (cohort II), a subspecies of Wistar with similar physi-
ology and behavior (Andersen and Tuﬁk, 2016), was reared at the ani-
mal care facility of the University of California, Riverside (UCR). The
experiments were performed in accordance with NIH guidelines for
care and use of laboratory animals andwith the approval of the Projects
and Ethics Committee of the INPRFM and the IACUC of the UCR.
2.2. Chemicals
Commercial PCB mixture, Aroclor 1254 (purity N 99%; Lot: 124-191-
B), was obtained from Accustandard, New Haven, CT. The constituent
PCB congeners (pg/ng) based on ortho-substitutions in this PCBmixture
were: non-ortho 0.02%; mono-ortho 24.1%; di-ortho 53.8%; tri-ortho
21.2%; tetra-ortho 0.85% (Kodavanti et al., 2001). Commercial PBDE
mixture, DE-71 (technical pentabromodiphenyl oxide; CAS no. 32534-
81-9; Lot 2550OA30A) was obtained from Great Lakes Chemical Corpo-
ration, West Lafayette, IN. The composition of individual congeners in
DE-71 was: PBDE-47 (36%); PBDE-99 (42%); PBDE-100 (10%); PBDE-
153 (3%); PBDE-154 (4%); and PBDE-85 (2%). The remaining 3% consists
of several identiﬁed tri-heptaBDEs and some unidentiﬁed PBDEs
(Dunnick et al., 2012).
2.3. Perinatal exposure to A1254 and DE-71
Perinatal exposure was accomplished by feeding pregnant dams
(n= 25, Wistar and n= 8, SD) with snacks (popcorn or Cheetos) in-
fused with A1254 (30 mg/kg/day) dissolved in corn oil vehicle or in-
fused with vehicle only (controls), for 10 days during gestation (GD
10-19) (cohort I, II). Although A1254 was administered prenatally,
the offspring was still exposed via breast milk. Several studies have
shown that PCBs have a longer half-life (Tanabe et al., 1981) and slowly
decrease in breastmilk throughout lactation (LaKind et al., 2009; Takagi
et al., 1986). Due to this, A1254 exposure was considered as perinatal
exposure. Cohort III: Wistar pregnant dams (n = 10), received snacks
dosed with the commercial penta-PBDE mixture DE-71 (30 mg/kg/d)
dissolved in corn oil vehicle or with vehicle only (control), from GD 6
to postnatal day (PND) 21. The volume of each dosing mixture in corn
oil was adjusted based on changes in the dam's weight. The pups
wereweaned and separated by sex at PND-22 andwere allowed toma-
ture until 3–5 months old.
175S. Mucio-Ramírez et al. / Toxicology and Applied Pharmacology 329 (2017) 173–189The dosing and experimental paradigm used in this study match
the experimental conditions in our previous reports (Coburn et al.,
2015; Kodavanti et al., 2010; Shah et al., 2011). Kodavanti et al.
(1998) where we showed that adult rats dosed orally with A1254
(30 mg/kg/day for 20 days), have brain tissue concentrations of
8.2–15.1 ppm or 20–50 μM. Such tissue concentrations have been
shown to disrupt neuronal signaling without producing overt cell
death (Kodavanti and Tilson, 2000). For reference, brain PCB levels
of up to 29.5 ppm (w/w) and until 80 ppm (fat weight basis) have
been found in wildlife exhibiting overt neurological symptoms
(Gabrielsen et al., 1995; Skaare et al., 2000; Kodavanti, 2005). For
PBDEs in a regimen of 50 ppm in food pellets from gestational day
8 to postnatal day 14, brain tissue concentration was 1.2 μg/g weight
tissue (Rickert et al., 1978). We used this high dose and the same lot
numbers of A1254 or DE-71 that were proven to produce neurotox-
icity in previous studies (Kodavanti et al., 2010; 2001; Kodavanti
andWard, 2005). Delivery of toxicants via dietary snacks has consis-
tently proven to be an effective method of oral exposure in our lab
and others using different snacks or mixed in pellets (Coburn et al.,
2015; Coburn et al., 2005; Kodavanti et al., 2010; Rickert et al.,
1978). A1254 at 30 mg/kg/day of exposure could reduce litter size
(Brezner et al., 1984). Therefore, at PND 4 the offspring number
was adjusted to eight pups per dam. The pup ratio was 60% females
and 40% males (4–5 females/l).
At 3–5 months of age (250–450 g), the pups of the litters were ran-
domly assigned for the different groups of analysis, so pups of the same
litter were included in different groups of analysis, (maximum two fe-
male or male pups were chosen) (Table 1). Cohort I, male and female
Wistar rats, controls and A1254 exposed, were assigned to three groups
of analysis: brain tissues were analyzed for immunoﬂuorescence for
AVP (n = 15 males, 13 females); endpoint RT-PCR analysis of cFOS, (n
= 12 males, 12 females), and in situ hybridization for AVP (n = 14
males, 20 females). All groups included four treatment conditions:
euhydrated rats (Control) and exposed to A1254; salt-loaded control
rats (Hyper) and exposed (Hyper + A1254). Special care was taken to
make sure that all female rats in the different groups were in the same
phase of the estrous cycle. Cohort II, adult male SD rats (n = 18) were
processed with immunoperoxidase to stain AVP as previous report
(Khan et al., 2000). This group included four treatment conditions:
euhydrated rats (Control) and exposed to A1254; with acute
hyperosmotic challenge control (Hyper) and exposed (Hyper
+ A1254) rats. Cohort III, Wistar male rats (n = 15), were processed
for immunoﬂuorescence to stain AVP. This group included ratsTable 1
Cohort distribution, rat strains used, dosing pattern pups used, and testing paradigm.
Cohort Dams/pups
(used)
Chemical and
doses
Osmotic challenge Treatment
groups
I Wistar
25/86
A1254
30 mg/kg/day orally
GD: 10–19
Euhydrated (Tap water) Control
A1254
Prolonged (Salt Loading)
Section 2.4
Hyper
Hyper + A1254
II SD
8/18
A1254
30 mg/kg/day orally
GD: 10–19
Euhydrated (0.154 M NaCl
sol. i.p.)
Control
A1254
Acute (3.5 M NaCl sol. i.p.)
Section 2.5
Hyper
Hyper + A1254
III Wistar
10/15
DE-71
30 mg/kg/day orally
GD: 6 to PND 21
Euhydrated (Tap water) Control
DE-71
Prolonged (salt loading)
Section 2.4
Hyper
Hyper + DE-71
Table shows cohort distribution, strain of rats, dosing pattern, number of offspring used, treatm
(A1254) or PBDE (DE-71)mixtures (30mg/kg/day, orally). ForA1254, the exposurewas fromge
postnatal day (PND) 21. At 3–5months of age (250–450 g), before sacriﬁce, somemale and fem
drinking solution during 5 days ad libitum) or acute (ip; 3.5 M NaCl) osmotic challenge. Pups
munoﬂuorescence (AVP-IF), AVP-mRNA in situ hybridization histochemistry (ISHH) and cFOS
II: AVP immunoperoxidase (AVP-IP). For cohort III: AVP-IF. The paradigms included four treatm
(Hyper) and exposed (Hyper+A1254 or DE-71) rats. All groups included plasma osmolality meuhydrated control and exposed to DE-71; salt-loaded control (Hyper)
and exposed (Hyper + DE-71), (see Table 1).
2.4. Prolonged osmoregulatory challenge (salt loading)
To determine if perinatal exposure to A1254 or DE-71 alters AVP
content and synthesis in the PVN and SONof euhydrated and physiolog-
ically activated animals, a subset of A1254 and DE-71-treated or control
rats (from each cohort) were exposed to a chronic hyperosmotic chal-
lenge. Itwas carried out by replacing their drinkingwaterwith 2% saline
solution (20 g NaCl/l; ad libitum access) for 5 days, as previously de-
scribed (Curras-Collazo and Dao, 1999; Amaya et al., 1999). Rats were
weighed before and after the hyperosmotic challenge. They were con-
sidered dehydrated when they lost about 10% of their body weight
(data not shown). These were labeled as hyperosmotic rats (Hyper).
Euhydrated (normosmotic) rats (control and treated) had ad libitum
access to tap water.
2.5. Acute osmoregulatory challenge
To determine whether perinatal A1254 exposure had effects on AVP
immunoreactivity after acute hyperosmotic challenge, a group of SD
male offspring 3–5 months old (n = 18) was used. Male offspring
were injected intraperitoneally (ip; 0.6 ml NaCl/100 g b.w.) with either
3.5MNaCl (Hyperosmotic solution) or 0.154MNaCl (0.9%NaCl isotonic
solution; Control) and animalswere sacriﬁced 4–4.5 h later as described
(Ludwig et al., 1994; Coburn et al., 2015). This manipulation has been
shown to produce marked stimulation of somatodendritic AVP release
(Coburn et al., 2015; Ludwig et al., 1994). Tail bloodwas collected before
sacriﬁce and plasma osmolality was measured to conﬁrm increased
plasma osmolality in Hyper rats of 5.0% or greater.
2.6. Tissue processing
Upon completion of the osmotic challenge, all rats were anesthe-
tized with sodium pentobarbital (63 mg/kg). They were transcardially
perfused with a clearing solution (150–200ml of 0.9% saline containing
2500 IU/500 ml heparin (PISA Farmacéutica Mexicana Mex.) followed
by 350–400 ml of 4% paraformaldehyde (Sigma Chemical Co., St. Louis,
MO) in PBS (0.1 M phosphate-buffered saline, pH 7.4). Brains were re-
moved and postﬁxed in the same ﬁxative at 4 °C for 2 h. They were
then cryoprotected in 30% sucrose and stored at 4 °C until used. Coronal
slices (30 μm) through the hypothalamic PVN and SON (Bregma:−0.80Osmolality AVP-IF or AVP-IP AVP-mRNA ISHH cFOS mRNA
RT-PCR
8 M, 4 F
8 M, 4 F
15 M,13 F
Section 2.8, Section 2.11
Stat: 2-way ANOVA
14 M, 20 F
Section 2.12
Stat: 2-way ANOVA
12 M,12 F
Section 2.13
Stat: 2-way ANOVA10 M, 3 F
9 M, 4 F
5 M
4 M (No data)
18 M
Section 2.9
Stat: 1-way ANOVA4 M
5 M
4 M, 4 F
3 M, 7 F
15 M
Section 2.8, Section 2.11
Stat: 1-way ANOVA4 M, 3 F
4 M, 6 F
ent groups, and testing paradigm for the perinatal exposure to commercial Aroclor 1254
stational day (GD)10 to 19. For DE-71, the exposure started at GD6 and continued through
ale rats from control and A1254 or DE-71 exposedwere subjected to a prolonged (NaCl 2%
were randomly assigned for the different groups of analysis. For cohort I: vasopressin im-
-mRNA ﬁnal point reverse transcription polymerase chain reaction (RT-PCR). For cohort
ents groups: euhydrated (Control) and exposed (A1254 or DE-71) rats, salt-loaded control
easurements.
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ing microtome (Leitz, Grand Rapids, MI) and collected in plastic wells
containing PBS. Serial sections were placed alternately in six wells con-
taining eight cuts per well approximately. Each well had a set (eight
slices) of all representative rostrocaudal PVN and SON. Free-ﬂoating
sections from three sets were processed for immunohistochemistry.
2.7. Osmolality
Under anesthesia and prior to perfusion, 2 ml cardiac blood samples
were collected from each rat and centrifuged at 8000 rpm for 5 min.
Osmolalitywasmeasured in triplicatewith a vapor pressure osmometer
(Wescor 5500, Logan, UT). Results for osmolality are reported as mean
± s.e.m. in mOsm/kg units.
2.8. Immunoﬂuorescence for AVP
Immunoﬂuorescence was carried out in Wistar rats from cohorts I
and III that included four treatment groups for A1254: Control (n = 4
males, 3 females), A1254, (n = 3 males, 3 females), Hyper (n = 5
males, 4 females), and Hyper + A1254 (n = 3 males, 3 females). For
DE-71 (male rats): Control (n = 4), DE-71 (n = 3), Hyper (n = 4),
and Hyper + DE-71 (n = 4) (see Table 1). The sections containing an-
terior, middle, and posterior hypothalamic PVN and SON regions were
processed simultaneously for all groups of each A1254 or DE-71 studies.
They were incubated in blocking solution containing 5% normal donkey
serum, 5% BSA, and 0.3% Triton X-100, for 60 min at room temperature
to minimize nonspeciﬁc staining. Then, the sections were incubated
with vasopressin-neurophysin antibody (PS-41 monoclonal, gifted by
H. Gainer, NIH) (Ben-Barak et al., 1985; Whitnall et al., 1985) at a
1:200 dilution in blocking buffer containing 1% teleostean gelatin
(Sigma Chemical Co., St. Louis, MO), for 48 h at 4 °C in free ﬂotation
with continuous shaking. The sections were then washed for three
times for 10 min each in PBS-T (PBS with 0.3% Triton X-100) followed
by a 1.5 h incubation with Alexa Fluor 488 donkey anti-mouse second-
ary antibody (Invitrogen Corp., Carlsbad, CA) at 1:200 dilution in
blocking solution, in a humidiﬁed chamber at 37 °C. Afterward, the sec-
tions were washed (3 × 10 min) in PBS and mounted onto glass slides
with an anti-fade mounting medium (ProLong Antifade Kit, Molecular
Probes; Eugene, Oregon USA). For several sections obtained from each
group, the primary antibody was replaced by blocking solution
representing methodological control sections. Staining observed in
these sections was used in background correction as part of computer-
assisted densitometry (see below). The structures in the immunohisto-
chemical control sections in which the ﬂuorescence was not observed
were considered immunoreactive to AVP. The sections were analyzed
with a Zeiss 510 META laser scanning confocal microscope, equipped
with a 488-nm argon-ion laser (Alexa Fluor 488 dye) attached to an
Axiovert 200 M microscope. They were analyzed with a 10× Plan-
Neoﬂuar NA = 0.3 and a 20× Plan-Neouﬂuar NA = 0.5 Objective
(Carl Zeiss). Before analyzing the sections, we conducted a lambda
stack to obtain the emission spectrum of this ﬂuorophore. Barrier ﬁlters
were placed to obtain only the peakﬂuorescence emission. Images from
each section (30 μm thickness) were acquired and analyzed bilaterally
on the optimal focal plane, in single track mode, with the Ar laser/
488 nm, pinhole diameter (1 airy unit) and detector gain (1). Laser
power was adjusted to provide an optimal dynamic range for the mea-
surements (the same in all slides). Confocal images were converted to
an 8-bit TIF format with a Zeiss LSM image browser (v 3.5).
2.9. Immunoperoxidase for AVP
After acute hyperosmotic challenge, animalswere ﬁxed as above (4%
paraformaldehyde). Coronal brain sections (40 μm) of perinatal A1254
exposed male Sprague-Dawley rats (n = 18), were processed with
immunoperoxidase to stain AVP. The technique was carried out aspreviously reported (Khan et al., 2000). Brieﬂy, brain sections were
mounted on gelatin-subbed glass slides. In each experiment control sec-
tions received all solutions except the primary antibody (methodologi-
cal control). Sections on slides were washed in PBS and treated with
blocking/permeabilization solution (0.2% gelatin, 0.3% Triton-X, 0.4%
BSA) for 30min. Tissue was incubatedwith an AVP antibody PS41, dilu-
tion 1:100. After wash, the sections were incubatedwith an anti-mouse
secondary antibody (Dako; K4001). AVP immunoreactivity was devel-
oped in nickel intensiﬁed 3,3′-Diaminobenzidine solution. Sections
were dehydrated in an alcohol series and coverslipped using DPX
mounting medium (Electron Microscopy Sciences), later analyzed
using bright ﬁeld microscopy and images were taken of PVN and SON
(3–7 images per nucleus per rat) using a digital camera (Spot Insight
Meyer).
2.10. Image analysis
All images were analyzed for integrated optical density (IOD) using
computer-assisted densitometry software (Image Pro Plus 4.5, Media
Cybernetics, MD, USA). Images were converted to a gray scale (0–255)
and their background was subtracted. Subsequently, the IOD of the im-
munoreactivity was quantiﬁed for the area of interest. The PVN and the
SON areas were manually outlined in at least six sections per nucleus
per rat. Integrated density values (density × area) were determined
per section for each nucleus. The IOD was reported as arbitrary units.
Average IOD was obtained for each regions of interest (bilateral PVN
and bilateral SON) by pooling IOD values of rats in respective experi-
mental groups.
2.11. Cell count analysis of AVP-IR neurons
To determine if A1254 or DE-71 exposure affected the number of
vasopressinergic neurons or only the intensity of AVP immunoreactivity
(measured with an IOD analysis), we counted the AVP immunoreactive
(AVP-IR) neurons in PVN and SON for all male groups (cohort I, III). We
selected 3–5 immunoﬂuorescent micrographs, of PVN and SON—only
the medial portions—for each animal in each group, for IOD quantiﬁca-
tion (Bregma: −1.80 mm to −1.88 mm for PVN and −1.30 mm to
−1.40mmfor SON) (Paxinos andWatson, 1998). Neuronswith evident
nuclei and AVP immunoreactivity were considered. To avoid counting
the same neurons more than once, we overlaid a grid with square sec-
tions (24.5 × 24.5 μm) on the images and counted the cells that were
marked with a X. For this analysis, we used Image-J software with the
plugin analyzer-cell counter (v 1.44p, National Institute of Health, avail-
able at http://imagej.nih.gov/ij).
2.11.1. Cell count analysis of Nissl staining. In addition to analyze the
possible changes in the overall cell densitywe counted the total number
of cells in the above-mentionedmedial portions of the PVN and the SON
in Nissl-stained sections of normosmotic control and A1254- and DE-
71-exposed adult male rats. The brains of four control and three
A1254- or DE-71-exposed rats were ﬁxed and collected as previously
described. For Nissl staining, coronal brain slices (30 μm thick) were
mounted on gelatin-coated slides and dried overnight. The sections
were immersed in a solution (100 ml) containing cresyl-violet (0.5%),
sodium acetate (2.7%), and glacial acetic acid (0.92%), for 2 min. Then,
sections were dehydrated through a series of graded ethyl alcohols
(70%, 80%, 96%, each for two minutes; 100% twice for two minutes),
cleared in xylene twice (5 min), and cover-slipped with Entellan resin
(Merck, Germany). Cells were counted with the aforementioned
procedures.
2.12. In situ hybridization histochemistry (ISHH)
We conducted in situ hybridization to determine the anatomical dis-
tribution of AVP mRNA and to determine the effect of perinatal
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sponse to hyperosmotic activation. Male and female rats perinatally ex-
posed to A1254 or vehicle, were allowed to mature to 3 months of age,
and randomly assigned to four experimental groups: 1) control (n = 4
males, 5 females), 2) A1254 (n = 3 males, 5 females), 3) Hyper (n= 3
males, 4 females) and 4)Hyper+A1254 (n=4males, 6 females). Both
control and exposed rats were randomly selected to be dehydrated. The
ﬁxed tissue (4% paraformaldehyde) was processed in the same way as
for immunohistochemistry (see above), except that materials and solu-
tionswere RNAse free. A series of 18-μm thick coronal sectionswere cut
through the rostrocaudal extent of the PVN and the SON on a cryostat
(Microm HM525, GmbH, Germany). Every fourth section cut through
the PVN or the SON was collected and mounted onto Superfrost/Plus
glass slides to obtain four sets for each PVN and SON. Sectionswere des-
iccated overnight at 42 °C and stored at−80 °C until processed for in
situ hybridization histochemistry.
2.12.1. AVP probe for ISHH. The 200 bp-DNA fragment containing AVP
was ampliﬁed by PCR using male or female rat cDNA from the PVN as a
template. Two oligonucleotides were chosen using the Primer3 (v.
0.4.0) software [http://bioinfo.ut.ee/primer3-0.4.0/primer3/] with an
introduction of a restriction enzyme site for posterior steps of
subcloning. Sense SHindIII 5′- TCA GTC AAG CTT CAC CTC TGC CTG
CTA CTT C -3′, which introduced aHindIII restriction site (bold), and An-
tisense EcoRI 5′- TAC TAT GAA TTC GGG GTA CAG GTT CTC CTC C -3′,
which introduced an EcoRI site (bold). The PCR conditions were 27 cy-
cles at 94 °C - 1 min, 64 °C − 1 min, 72 °C − 1.15 min, and a ﬁnal
cycle at 72 °C− 10 min.
The resulting PCR product was extracted and puriﬁed with the High
Pure PCR Product Puriﬁcation Kit (Roche, Mannheim, Germany). The
puriﬁed fragment was cloned into the pJET1.2/blunt vector from
CloneJET™ PCR Cloning Kit (Fermentas) as speciﬁed by themanufactur-
er, with the ligation reaction at 22 °C for 20 min. The ligation mixture
was electro-transformed using 50 μl of electrocompetent DH5α cells
and was incubated at 37 °C for 1 h. Subsequently, the electroporated
cells were poured into Petri dishes containing 2xYTmedium and ampi-
cillin (200 mg/ml ﬁnal concentration) and were incubated at 37 °C for
12 h.
To select positive colonies containing the vector and vasopressin
fragment, we performed a colony PCR using SHindIII and AsEcoRI and
the above-described PCR conditions. Plasmids of selected colonies
were isolated according to a standard alkaline lysis protocol, and sin-
gle-pass sequencing of the 5′-termini was conducted with the pJET1.2
Forward Sequencing Primer (5′-CGA CTC ACT ATA GGG AGA GCG GC-
3′) and an automated analyzer (Model 3100, Applied Biosystems, Foster
City, CA), as speciﬁed by the manufacturer.
The pJET plasmid containing vasopressin was digested with the
HindIII and EcoRI restriction enzymes, and the released fragment was
extracted from agarose gel and subsequently puriﬁed using the High
Pure PCR Product Puriﬁcation Kit. The puriﬁed fragment was ligated
into a pSPT18 vector (Roche, Cat. 10,999,644,001), previously digested
with HindIII and EcoRI enzymes, using T4 DNA ligase, as per the instruc-
tions of the manufacturer. The ligation was electroporated into
electrocompetent DH5α cells, and plasma DNA from four colonies was
sequenced using SHindIII and AsEcoRI to conﬁrm the presence of the in-
sert containing AVP. Transcripts obtained from the four clones gave the
expected mRNA distribution pattern for AVP in the CNS when used as a
probe for ISHH (not shown).
2.12.2. ISHH technique. Every fourth section of the PVN and the SON
was hybridized with a 200-bp single-stranded α [35S] UTP-labeled
RNA probe, complementary to the coding region of the rat AVP gene
(47 to 247 nucleotides of the cDNA; GenBank: M25646.1). Hybridiza-
tion was performed as previously described (Sanchez et al., 2009). The
tissues were pre-treated in 50% formamide/2× SSC. The hybridizations
were performed in a buffer containing 50% formamide, 2× SCC, 10%dextran sulfate, 1× Denhardt's [0.25% BSA, 0.25% Ficoll 400, 0.25% poly-
vinylpyrrolidone], 0.25% 1MTris-HCl pH 8.0, 5% sodiumdodecyl sulfate,
250 μg/ml denatured salmon sperm DNA, and a 5 × 105 cpm
radiolabeled probe at 54 °C for 16 h. Slides with hybridized brain sec-
tions were dipped into Kodak NTB autoradiography emulsion (East-
man Kodak) diluted 1:1 in distilled water. These slides were
developed after 4 days of exposure at 4 °C. Developed silver grains
analyzed from the hybridized slides were visualized under dark-
ﬁeld illumination (Olympus BX51, 10×/0.3 NA objective). Images
were obtained with a SPOT II digital camera (Diagnostic Instruments,
Inc.), the areas of interest (PVN and SON) were outlined. IOD values
were estimated in each sectionwith background correction (as back-
ground the adjacent tissue without AVP mRNA signal was taken).
The speciﬁcity of the signal was demonstrated in hybridized tissue
using the sense probes. Blind quantitative analysis was performed
independently by two observers, without major differences among
them. The average of the IOD values of up to six rostrocaudal slices/
animal was calculated, treated as one determination, and was used
to estimate the mean and s.e.m./group. Two different repetitions
were performed and analyzed twice by independent ISHH trials on
different sets of sections, giving similar results.2.13. Endpoint reverse transcription polymerase chain reaction (RT-PCR)
Endpoint RT-PCR to cFOS gene expression was performed to deter-
mine if the PVNand SONof A1254 perinatally exposed rats are activated
in response to hyperosmotic challenge. We used three-month-old rats,
12 females and 12 males (Control, A1254, Hyper, Hyper + A1254; n
= 3 rats per sex per group). Upon completion of the osmotic challenge,
the rats were killed by rapid decapitation with a guillotine, and trunk
blood was collected to determine plasma osmolality. The brains were
rapidly removed from the skull, placed on dry ice, and stored at−80
°C until use. Brains were sectioned on a cryostat until reaching the be-
ginning of the regions of interest, taken out on dry ice and cut frozen
into a thick coronal section in a range of−1.30 to−2.12 mm for the
PVN and−0.80 to−1.80 mm for the SON caudal to Bregma (Paxinos
and Watson, 1998). The PVN and the SON were punched out of the tis-
sue using the micropunch technique (Palkovits, 1988) and kept frozen
in a tube on dry ice. Total RNA was extracted as described
(Chomczynski and Sacchi, 1987), and RNA concentration was deter-
mined by absorbance at 260 nm. Only samples with a 260/280 nm
ratio of N1.8 and N2.0 28S/18S ratio, veriﬁed by gel electrophoresis in
1% agarose -1× TBE, were used. Onemicrogram of RNAwas transcribed
with M-MLV reverse transcriptase and oligo-dT. The 18S was used as
reference gene. PCR reactions were performed as follows, 1336–1553
of 18S ribosomal RNA (rRNA) cDNA (GenBank: X01117.1); ﬁnal prod-
uct: 218 bp; sense: 5′- ATGGCCGTTCTTAGTTGGTG -3′, antisense: 5′-
CGCTGAGCCAGTTCAGTGTA -3′. For cFOS cDNA, sense: 5′
-CAATACACTCCATGCGGTTG -3′, antisense: 5′ –
CCCGTAGACCTAGGGAGG AC-3′. To ensure adequate conditions for the
semi-quantiﬁcation of mRNA expression for each probe, cDNAs pre-
pared from1.0 μg of RNA in the PVNand SONwere subjected to PCR am-
pliﬁcation cycles (Mastercycler, Ependorff, Hamburg, Germany). The
number of cycles for each cDNA was obtained from the ascending part
of the curve that plots optical density versus number of PCR cycles.
18S rRNA: 2 μl of cDNA per 25 μl PCR [94 °C 1′15″, 65 °C 1′, 72 °C 1′]
× 30 cycles + 15 min at 72 °C for a ﬁnal extension. cFOS: 2 μl of cDNA
per 25 μl PCR [94 °C 1′15″, 60 °C 1′, 72 °C 1′] × 32 cycles + 15 min at
72 °C for a ﬁnal extension. Productswere separated by gel electrophore-
sis in 2% agarose -1× TBE, running buffer (0.5×), and stained with
ethidium bromide; density was quantiﬁed with a Fluor-S MultiImager
(BioRad). Samples of control and experimental animals from the
same group were included in the same gel. The relative values for
cFOS mRNA were estimated as the ratios of mRNA signal to 18S rRNA
signal.
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Statistical signiﬁcance between groups was determined by one or
two-way ANOVA depending on the factors tested. For two-way
ANOVA the factors tested were sex and treatment, while data from
males was assessed with one-way ANOVA (treatment). Where overall
signiﬁcance was obtained (p b 0.05), post-hoc comparisons were
made using Holm-Sidak method. Results for osmolality are reported as
mean ± s.e.m. in mOsm/kg units. Average values from each cohort
were statistically analyzed in an independent way using two-way
ANOVA for cohort I and III and one-way ANOVA for cohort II.
For AVP immunoﬂuorescence and immunoperoxidase, the mean
IOD values were tested with two-way ANOVA (cohort I), and one-way
ANOVA (cohort II, III). For cell counting, averages of immunoreactive
neurons from cohort I and III were evaluated with one-way ANOVA.
Nissl-stained neurons were analyzed using one-way ANOVA. For ISHH,
the mean IOD values were tested with two-way ANOVA (cohort I). For
endpoint reverse transcription polymerase chain reaction (RT-PCR),
the statistical signiﬁcance between groups was determined by two-
way ANOVA (cohort I). Statistical analysis was performed using
SigmaPlot 12.3 (Systat Sofware, Inc). ANOVA was performed where
data met normality and homogeneity of variance assumptions. Statisti-
cal signiﬁcance was acknowledged at an alpha level of 0.05.
3. Results
3.1. Perinatal A1254 and DE-71 treatment affect osmoregulatory capacity
during hyperosmotic challenge in adulthood
Cardiac blood was collected and analyzed for plasma osmolality
(Table 2) from the three cohorts. Plasma responses were measured in
normosmotic conditions: corn-oil vehicle (Control); A1254 (A1254) or
DE-71 (DE-71) exposed, and in rats subjected to prolonged or acute
hyperosmotic challenge: corn-oil vehicle (Hyper); exposed to A1254
(Hyper + A1254), or DE-71 (Hyper + DE-71). In all cohorts plasma os-
molality data showed an expected elevation in response to
hyperosmotic stimulation. Cohort I (males and females perinatal ex-
posed to A1254 and subjected to prolonged hyperosmotic challenge)
was evaluated with two-way ANOVA (sex and treatments). Plasma os-
molality values were not signiﬁcant differences between sexes (F1,147
= 1.56, p=0.21); there was no interaction between sex and treatment
(F3,147 = 0.77 p= 0.51). There was a statistically signiﬁcant difference
in the mean omoslality values between the treated groups (F3,147 =
9.17, p b 0.001). Post-hoc multiple comparison testing showed thatTable 2
Plasma osmolality (mOsm/kg) in adult rats perinatally exposed to A1254 or DE-71 and in resp
Cohort Experimental
conditions
Hyper
Prolon
PCBs Control A1254 Hyper
I W. Males + Females 303.3 ± 4 n=M8, F4 324.8 ± 4.8 n=M8, F4 331.8
II SD. Males 297.3±1.7 (n=5)
PBDEs Control DE-71 Hyper
III W. Males 307.2 ± 2.0 (n=4) 306.3 ± 2.3 (n=3) 333.7
W. Females 313.3 ± 1.9 (n=4) 299 ± 2.0† (n=7) 336.3
Table shows osmoregulatory capacitymeasured during normosmotic and hyperosmotic conditi
to A1254 or DE-71 (30 mg/kg/day orally) or corn-oil vehicle (Control). Rats from these group
5 days ad libitum) or acute osmotic challenge (NaCl 3.5 M i.p.), (Hyper; Hyper+A1254 or Hy
was measured and the values are expressed as mean ± s.e.m. in mOsm/kg. Average values from
I and III and one-way ANOVA for cohort II, followed by post-hoc comparisons using the Holm-S
teractions between sexes and between sex and treatment. This is the reason that it is depicted as
ANOVA. Asterisks (*) compared to control, number symbols (#) compared toHyper, carets (^) c
= ^,†, p b 0.01 = ⁎⁎, ##, p b 0.001 = ⁎⁎⁎, ###, ^^^).Hyper and Hyper + A1254 group had a signiﬁcant increase in plasma
osmolality relative to normosmotic controls (p = 0.002, p b 0.001 re-
spectively). Hyper+A1254 group showed a signiﬁcant increase in plas-
ma osmolality relative to A1254 group (p= 0.035).
Cohort II (males perinatally exposed to A1254 and subjected to acute
hyperosmotic challenge) was evaluated using one-way ANOVA. It
showed signiﬁcant differences between treatment groups (F2,13 =
12.6, p= 0.001). Multiple comparison revealed that both Hyper (p =
0.012) and Hyper + A1254 (p = 0.001) groups had a signiﬁcant in-
crease in plasma osmolality relative to control.
Cohort III (DE-71 perinatal exposure and subjected to prolonged
hyperosmotic challenge) was evaluated with two-way ANOVA. Plasma
osmolality values were not signiﬁcant different between sexes (F1,94
= 1.04, p= 0.31), but there was a signiﬁcant sex and treatment inter-
action (F3,94 = 4.31 p= 0.007). There were statistically signiﬁcant dif-
ferences in the mean osmolality values between the treated groups
(F3,94 = 54.4, p b 0.001). Post-hoc multiple comparison testing showed
that Hyper males and females had a signiﬁcant increase in plasma os-
molality relative to normosmotic controls (p b 0.001). Female Hyper
+ DE-71 rats showed a signiﬁcant increase in plasma osmolality rela-
tive to DE-71 normosmotic control (p b 0.001). A similar tendency
was seen in males but the effect was not statistically signiﬁcant (p =
0.11). Additionally, in both sex groups, Hyper+DE-71 rats showed sig-
niﬁcant lower plasma osmolality relative to Hyper group (p b 0.001).
There were not differences between males and females within control,
Hyper and Hyper+DE-71 groups (p N 0.05), but there was a signiﬁcant
sex difference within the DE-71 treatment (p= 0.011). In combination
these ﬁndings may indicate aberrant osmotic activation and/or dysreg-
ulation induced by developmental exposure to PBDEs in male and fe-
male adult Wistar and SD rats.
3.2. Perinatal exposure to A1254 prevents the AVP physiological response to
hyperosmotic challenge
3.2.1. AVP immunoﬂuorescence. Image analysis of coronal brain sec-
tions from the PVN and SON ofmale and female rats perinatally exposed
to A1254 and subjected to prolonged hyperosmotic challenge (cohort I)
shows that in control groups (vehicle) AVP-IR is mainly in MNCs. Basal
AVP-IR was abundant and uniformly distributed in soma and ﬁbers em-
anating from these nuclei (Fig. 1A, E). Perinatal exposure to A1254 leads
to increase the AVP-IR in PVN compared to control group (Fig. 1B, F).
Prolonged hyperosmotic stimulation (Hyper) showed an expected
physiological increase of AVP-IR relative to control groups. These differ-
ences are notable in MNCs cytoplasm and in some parvocellular cellonse to prolonged or acute hyperosmotic challenge.
osmotic challenge
ged Acute
Hyper + A1254 Hyper Hyper + A1254
± 5** n=M10, F3 346.4 ± 4.9^*** n=M9, F4
329.1 ± 4.4**
(n=4)
340.4 ± 9.6***
(n=5)
Hyper + DE-71
± 4.7*** (n=4) 314.8 ± 1.9### (n=4)
± 2.7*** (n=3) 320.9 ± 1.9^^^### (n=6)
ons inWistar (W) or SpragueDawley (SD) adult rats (3–5months old) perinatally exposed
s were subjected to prolonged hyperosmotic challenge (NaCl 2% drinking solution during
per+DE71groups). Under anesthesia, blood was collected at sacriﬁce. Plasma osmolality
each cohort were statistically analyzed independently using two-way ANOVA for cohort
idak method. For the plasma osmolality values from cohort I, there were no signiﬁcant in-
a single group. Symbols indicates signiﬁcant differences as determined by one or two-way
ompared to A1254 or DE-71 treatment and daggers (†) compared to the other sex (p b 0.05
Fig. 1.Effects of perinatal exposure toAroclor 1254 (A1254) onAVP immunoreactivity (AVP-IR) in 3-month-oldWistar rats. LEFT: Panel of representative confocal images frommale rats of
PVN and SON coronal sectionswith AVP-IR: control rats (images A and E); A1254-treated rats (30mg/kg/day) (images B and F); hyperosmotic salt-loaded rats (Hyper) (images C and G);
and hyperosmotic A1254-treated rats (Hyper + A1254; D and H). There was an increase in AVP-IR in Hyper rats (C and G). In contrast, there was an evident decrease in immunoreactive
intensity and number of AVP-IR neurons and ﬁbers after A1254 exposure (Hyper + A1254; D and H). RIGHT: The graphs show the effects of A1254 on AVP-IR integrated optical density
(IOD) in the PVN (a) and the SON (b) frommales and females. Therewere no signiﬁcant differences between sexes and no interactions between sex and treatment. This is the reason that it
is depicted as a single group. The dotted line shows the ROI used to perform IODmeasurements. The bars represent mean values± s.e.m. The symbols represent statistical signiﬁcance as
determinedby two-wayANOVA andHolm-Sidakpost-hoc tests. Asterisks (*) compared to control andnumber symbols (#) compared toHyper (*,#= p b 0.05; ⁎⁎= p b 0.01; ⁎⁎⁎###= p b
0.001). Abbreviations: third ventricle (3V); optic chiasm (OX); Bar = 100 μm.
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tensity of AVP-IR and the amount of the AVP-IR cells were lower in
the PVN and SON from the Hyper + A1254 group as compared to theFig. 2.A1254prevents upregulation of AVP-IR in response to acute osmotic activation in the SON
kg/day). LEFT: Representative micrographs were generated using AVP immunoperoxidase in P
subjected to an acute hyperosmotic challenge (Hyper; 3.5 M NaCl; 0.6 ml/100 g body weight
There was an increase in AVP-IR in Hyper rats (C and G). In contrast, there was a marked red
and ﬁbers in Hyper + A1254 group (D and H). RIGHT: Bars show mean ± s.e.m. values of AVP
by one-way ANOVA and Holm-Sidak post-hoc tests. Asterisks (*) compared to control, numbe
Calibration bar = 100 μm.A1254 and to the Hyper groups (Fig. 1D, H). These observations were
corroborated with semiquantitative analysis of the AVP-IR density
(Fig. 1a, b), evaluated with two-way ANOVA (sex and treatment).and PVNofmale Sprague-Dawley rats perinatally exposed to Aroclor 1254 (A1254; 30mg/
VN and SON sections. Control (vehicle) images A and E; A1254-treated rats B and F; rats
, i.p.) images C and G; and hyperosmotic A1254-treated rats (Hyper + A1254; D and H).
uction in upregulation of immunoreactive intensity and distribution of AVP-IR neurons
-IR IOD in PVN (a) and SON (b). Symbols represent statistical signiﬁcance as determined
r symbols (#) compared to Hyper (⁎⁎, ## = p b 0.01). Abbreviations: optic chiasm (OX);
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PVN (F2,63 = 3.18, p = 0.08) nor in the SON (F1,60 = 3.75, p = 0.05).
Neither was signiﬁcant interaction between sex and treatments in the
PVN (F3,63 = 2.08, p=0.11) or SON (F3,60 = 1.38, p=0.25). As expect-
ed, there were signiﬁcant differences between the treatments groups,
both in the PVN (F3, 63 = 6.05, p= 0.001) and SON (F3,60 = 18.56, p b
0.001). Multiple comparison indicated signiﬁcant differences when
comparing A1254 group with control group from PVN (p = 0.012).
Mean IOD values from the Hyper groups showed statistically signiﬁcant
increases compared to controls in PVN (p=0.004) and in the SON (p b
0.001). In contrast, themean IOD for theHyper+A1254 groupswas not
different from the controls. When comparing Hyper + A1254 to the
Hyper groups they have a signiﬁcant IOD decrease, (PVN p = 0.047;
SON p= 0.001; Fig. 1a, b). In the PVN, the comparison of Hyper group
versus Hyper + A1254, shows a reduction in the mean IOD values of
74.7% in males and 67.08% in females. In the SON this comparison
showed a reduction in mean IOD values of the 95% in males and
86.24% in females.3.2.2. AVP immunoperoxidase. AVP immunostaining in PVN and SON
sections of cohort II (adult males perinatally exposed to A1254 and sub-
jected to acute dehydration) showed similarly decreased AVP-IR re-
sponses to acute hyperosmotic stimulation when compared to rats
that were chronically activated (Fig. 2). First, AVP-IRwas uniformly dis-
tributed in soma and ﬁbers ofMNCs in PVN and SON. A1254 treated rats
had similar AVP-IR to controls in both nuclei. As in Cohort I Hyper rats
showedmore robust AVP-IR as compared to the control group. Upregu-
lated AVP-IR responses in the Hyper+ A1254 groupwere not observed
when compared to A1254 and Hyper groups both in PVN and SON.
Mean IOD values for AVP-IR were evaluated using one-way ANOVA. In
the PVN there were not signiﬁcant differences between groups (F3,14
= 3.10, p = 0.061). In the SON there were signiﬁcant effects between
treatment groups (F3,14 = 6.29, p = 0.006). Multiple comparison
showed that mean IOD values from Hyper group were signiﬁcantly
greater compared to control (p = 0.011). When comparing Hyper ver-
sus Hyper + A1254, IOD values decreased signiﬁcantly (p = 0.011;
Fig. 2a and b).3.2.3. AVP-IR in DE-71-exposed male rats. Brain sections of control
normosmotic groups have a medium intensity (basal) AVP-IR in the
PVN and the SON, mainly in MNC cell bodies (Fig. 3A, E). Sections
from DE-71-treated rats showed an increase in basal AVP-IR in PVN
and SON (Fig. 3B, F). Sections from Hyper rats showed an evident phys-
iological AVP-IR increase inMNCs and parvocellular neurons in the PVN
and inMNCs of the SON (Fig. 3C, G). Hyper+DE-71-treated rats did not
show this increase; rather, they had weak AVP-IR in the PVN and the
SON (Fig. 3D, H). Also the number of AVP-IR neuronswas reduced, ﬁnd-
ing conﬁrmed by cell count analysis (Fig. 4C, D). Mean IOD values for
AVP-IR are shown in the graphs of Fig. 3(a, b). The differences of the
mean IOD values for AVP-IR between the treatment groups were evalu-
ated using one-way ANOVA, Indicating signiﬁcant differences both in
the PVN and SON (F3,40 = 10.9, p b 0.001 and F3,45 = 14.54, p b 0.001
respectively). Multiple comparison showed, in the SON, that the IOD
values from DE-71 treated group were signiﬁcantly different compared
to the control group (p= 0.021). The Hyper groups from PVN and SON
showed statistically signiﬁcant increases compared to controls (p b
0.001 both). In contrast, the mean IODs for the Hyper + DE-71 groups
were not different from the controls. The Hyper+DE-71 group showed
a signiﬁcant decrease in the SON (p= 0.026), when compared with its
own control, the DE-71 group. When compared Hyper with Hyper
+ DE-71 groups, the mean IOD decreased signiﬁcantly in both PVN
and SON(p b 0.001both; Fig. 3a, b). These comparisons showed a reduc-
tion in mean AVP-IR IOD values of the 88.24% in the PVN, and 77.03% in
the SON.3.3. Cell count analysis of AVP-IR neurons
A cell count analysiswas performedwith same immunoﬂuorescence
images acquired from cohorts I and III male rats. Only the photographs
from the middle part of the PVN and the SON were used (Bregma:
−1.80 mm to−1.88 mm for the PVN, and−1.30 mm to−1.40 mm
for the SON) (Paxinos and Watson, 1998). Cell counts included all
AVP-IR MNCs and parvocellular neurons. One-way ANOVA indicated
signiﬁcant differences between treatment groups in the number of
AVP-IR neurons by A1254 treatment in PVN (F3,70 = 5.35, p = 0.002)
and SON (F3,45 = 22.14, p b 0.001). Multiple comparisons showed that
in A1254-treated rats, the number of the AVP-IR neurons in the PVN
and SON were not signiﬁcantly different compared to its control (Fig.
4A, B). The Hyper groups had a signiﬁcantly increased number of AVP-
IR neurons compared to control both in the PVN and in the SON (p =
0.002, p b 0.001 respectively). In the Hyper+A1254 group, the number
of AVP-IR neurons was similar to that of the control group, but signiﬁ-
cantly lower compared to the Hyper groups in PVN and SON (p =
0.026, p b 0.001 respectively). The Hyper + A1254 group showed a sig-
niﬁcant decrease in thenumber of neurons in the SONwhen itwas com-
pared with its own control, the A1254 group (p= 0.002) (Fig. 4B).
In the case of DE-71 exposure, the one-way ANOVA showed signiﬁ-
cant differences between treatment groups in PVN (F3,57 = 12.49, p b
0.001) and SON (F3,32 = 25.96, p b 0.001) (Fig. 4C, D). Pos-hoc multiple
comparisons showed that the number of AVP-IR neurons in the SON in-
creased signiﬁcantly in DE-71 group (p b 0.001) compared to the con-
trol. Hyper groups from PVN and SON had a signiﬁcantly increased
number of AVP-IR neurons compared to the control (p = 0.003, p b
0.001 respectively). When compared Hyper+ DE-71 with its own con-
trol, the DE-71 group, there was a signiﬁcant decrease in the number of
neurons in the SON (p b 0.001) (Fig. 4D). The Hyper + DE-71 groups
showed a signiﬁcant decrease in the number of AVP-IR neurons com-
pared to the Hyper groups in both nuclei (p b 0.001 both). These results
were similar to those observed for theA1254 exposed group (Fig. 4B, D).
3.3.1. Cell count analysis of Nissl staining. We used alternating brain
sections containing medial PVN and SON that were not processed for
AVP immunohistochemistry. Normosmotic control and A1254- and
DE-71-treated rats were randomly chosen from three different litters.
There was no statistically signiﬁcant difference in cell counts between
groups in PVN (F2,29 = 1.48, p = 0.243) and SON (F2,34 = 0.09, p =
0.914). The mean values ± s.e.m. from PVN and SON were graphed
(Fig. 4E, F). Further, Nissl-stained neurons seemed to have normal mor-
phological characteristics in all groups.
3.4. cFOS mRNA expression after perinatal exposure to A1254
The cFOS mRNA expression was assessed to demonstrate if neurons
of PVN and SON were activated. cFOS genes were evaluated together
with the reference gene 18S ribosomal RNA. Males and females perina-
tally exposed to A1254 and subjected to prolonged osmotic activation
were evaluated by two-way ANOVA. The IOD data indicated no statisti-
cally signiﬁcant differences between sexes, for the PVN (F1,15 = 2.04, p
=0.174) or SON (F1,16 = 3.32, p=0.087), nor did it show any interac-
tion between sex and treatment in the PVN (F3,15 = 1.18, p= 0.35) or
SON (F3,16 = 0.26, p= 0.857). As expected, there was a signiﬁcant dif-
ferences between treatment groups in PVN (F3,15 = 15.2, p b 0.001) or
in SON (F3,16 = 22.79, p b 0.001). Post-hoc multiple comparisons indi-
cated that Hyper groups from PVN and SON showed no signiﬁcant in-
crease of cFOS mRNA compared to control groups (p = 0.086, p =
0.366 respectively). However Hyper + A1254 group displayed the
highest cFOS mRNA expression in PVN and SON with a statistically sig-
niﬁcant increase as compared to control (p b 0.001 both); as compared
to A1254 groups (PVN p= 0.002; SON p b 0.001) and as compared to
Hyper (p= 0.002, p b 0.001 respectively), (Fig. 5A, B).
Fig. 3. Effects of perinatal exposure to DE-71 on AVP immunoreactivity (IR) in 3-month-old Wistar males rats. LEFT: Panel of representative confocal images of PVN and SON coronal
sections with AVP-IR: control rats (images A and E); DE-71-treated rats (30 mg/kg/day) (B and F); hyperosmotic salt-loaded rats (Hyper) (C and G); and hyperosmotic DE-71-treated
rats (Hyper + DE-71; D and H). AVP-IR increased in DE-71-treated and Hyper rats. In contrast, there was not physiological increase in staining intensity and number of AVP-IR
neurons in Hyper + DE-71 rats. These results were conﬁrmed with the IOD evaluation as showed in the graphs. RIGHT: The graphs show the effects of DE-71 on AVP-IR IOD in the
PVN (a) and the SON (b). The bars represent mean values ± s.e.m. The symbols represent statistical signiﬁcance as determined by one-way ANOVA and Holm-Sidak post-hoc.
Asterisks (*) compared to control, number symbols (#) compared to Hyper and carets (^) compared to DE-71 treatment (⁎,^= p b 0.05; ⁎⁎⁎, ### = p b 0.001). Abbreviations: third
ventricle (3V); optic chiasm (OX); Bar = 100 μm.
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Fig. 4. Effects of perinatal exposure to A1254 or DE-71 on the number of AVP-IR neurons and Nissl-stained cells, from the PVN and SON (A, B, C, D in 3-month-old male rats during
normosmotic and hyperosmotic conditions). Mean values for AVP-IR neurons increased signiﬁcantly after salt loading in vehicle-treated rats (Hyper) but not in salt loaded A1254- and
DE-71-treated rats (Hyper + A1254; A and B; Hyper + DE-71; C and D).These groups showed a signiﬁcant decrement when compared with Hyper groups. Graphs E and F showed no
change in the number of PVN and SON Nissl-stained cells of adult male rats perinatally exposed to A1254 or DE-71 (30 mg/kg). The bars represent mean ± s.e.m. values of AVP-IR
neurons, and Nissl-stained cells in control, A1254- and DE-71-treated rats. The symbols represent statistical signiﬁcance as determined by one-way ANOVA and Holm-Sidak post-hoc.
Asterisks (*) compared to control, number symbols (#) compared to Hyper and carets (^) compared to A1254 or DE-71 treatment (⁎,#p b 0.05; ⁎⁎, ^^p b 0.01; ⁎⁎⁎, ###, ^^^p b 0.001).
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In situ hybridization allowed us to identify and localize AVP mRNA
expression within the PVN and SON. Developed silver grains of the
ﬁlm, denoting AVP mRNA, were widely distributed in all MNCs and
some parvocellular neurons inmale and female PVN and SON brain sec-
tions (Fig. 6). IOD data from males and females were evaluated with
two-way ANOVA. The test indicated no statistically signiﬁcant differ-
ences between sexes in the PVN (F1,320 = 2.11, p = 0.147) and SON
(F1,249 b 0.001, p = 0.98). There was statistically signiﬁcant differences
in the mean IOD values between the treated groups (PVN; F3,320 =
33.75, p b 0.001, and SON; F3,249 = 24.35, p b 0.001). In addition, there
was an interaction between sex and treatment in the PVN (F3,20 =
3.46, p= 0.017). Post-hoc multiple comparisons indicated a signiﬁcant
increase in IOD values of AVP mRNA in the Hyper groups when com-
pared to the control in the PVN for males and females (p b 0.001, p b
0.004 respectively) and from SON in both sexes (p b 0.001; Fig. 6a, b).
Comparison of control and A1254-exposed rats revealed no signiﬁcant
differences. However, A1254 treatment blunted AVPmRNA levels in an-
imals subjected to prolonged hyperosmotic challenge, although someclusters with high signal intensity remained in the PVN and SON (Fig.
6D, H). When compared with the Hyper group, the AVP mRNA values
for Hyper + A1254 decreased signiﬁcantly in the PVN (p b 0.001 for
both males and females) and SON (p b 0.001). The percentage decrease
of Hyper + A1254 compared to the Hyper group was 68.12% in the
males and 63.86% in the females in the PVN, and an average of 54.57%
for both males and females in the SON. There were not differences be-
tween males and females within control, A1254 and Hyper + A1254
groups (p N 0.05) in the PVN, but there was a signiﬁcant sex difference
within the Hyper groups (p= 0.005).
4. Discussion
4.1. Perinatal exposure to A1254 and DE-71 disrupts AVP responses to
hyperosmotic challenge in the PVN and SON of adult rats
This study demonstrates that perinatal exposure to organohalogen
pollutants such as PCBs and PBDEs adversely affects the
vasopressinergic system in adult rats. This effect was evident when
the MNC system was stimulated by physiological demand such as
Fig. 5. Effects of perinatal exposure to A1254 on semiquantitative endpoint RT-PCR analysis of cFOSmRNA in 3-month-oldmales and femalesWistar rats. Analyses ofmicropunches taken
from the PVN (A) and the SON (B) were carried out in control rats (oil vehicle and normosmotic), rats perinatally exposed to A1254, rats hyperosmotically stimulated (Hyper), and rats
treatedwith A1254 and prolonged salt-loading (Hyper+ A1254). Densitometric analyses (arbitrary units) for cFOSmRNA normalized to the 18S rRNA reference gene revealed that there
were no signiﬁcant differences between sexes and no iteractions between sex and treatment. This is the reason that it is depicted as a single group. The A1254 and Hyper groups increased
lightly but did not were signiﬁcantly different compared to control group. The Hyper+ A1254 groups for both PVN and the SON showed the greatest increasewhen compared to control,
A1254 and Hyper groups. The bars represent mean IOD ± s.e.m. Below each bar there is one example from each sex of the electrophoresis bands from cFos and 18S rRNA. Statistical
signiﬁcance was determined by two-way ANOVA and Holm-Sidak post-hoc test. The symbols represent statistical signiﬁcance, asterisks (*) compared to control, number symbols (#)
compared to Hyper and carets (^) compared to A1254 or DE-71 treatment (⁎⁎⁎, ###, ^^^p b 0.001).
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hyperosmotic stimulus promotes an increase in AVP content in the hy-
pothalamic PVN and SON and plasmaAVP release. Circulating AVP leads
towater retention by the kidneys andmaintains plasma volume and os-
molality (Ludwig et al., 1994; Weitzman and Kleeman, 1979). Also,
hyperosmotic stimulation promotes release of AVP from
somatodendritic components of MNCs (central AVP release) which
autoregulates plasma AVP release to prevent excessive axonal AVP re-
lease during physiological demand (Liu et al., 1996; Ludwig et al.,
1994). The rise in AVP content within MNC nuclei is a normal neuroen-
docrine response by the hypothalamo-neurohypophysial system to an
increased physiological demand (Amaya et al., 1999; Bourque, 2008;
Johnson and Thunhorst, 1997). This is also accomplished by increased
hydration via water drinking, in the salt-loaded model and in acute
hyperosmotic challenge the animals were not allowed to drink water,
thereby they were forcing the system to maintain osmotic balance
(Leng et al., 2001, 1999; Ludwig et al., 1996). The expected physiological
increase in AVP-IR in salt-loaded rats (Hyper group) (Fig. 1C, G; Fig. 3C,
G) was found in cell bodies in both the PVN and the SON, mainly in
MNCs, but also in parvocellular neurons as reported by our lab and
others (Amaya et al., 1999; Elgot et al., 2012; Gamrani et al., 2011;
Whitnall and Gainer, 1985). The large increase in immunoreactivity to
AVP-neurophysin antibody is representative of the AVP peptide and
has been shown to be associated with secretory granules in MNCs
(Ben-Barak et al., 1985; Whitnall and Gainer, 1985). The quantiﬁed
values of IOD should not be taken as a linear index of the intracellular
concentrations of the peptide, as the size of the sample was not large
(3–5 rats per treatment, over six slides per nucleus -two nuclei for
brain). In spite of these limitations, the observed AVP IOD values likely
reﬂect changes in AVP content within both the PVN and the SON. Our
results showed that adult rats (3 months old) perinatally exposed to
commercial PCB and PBDE mixtures (A1254 and DE-71, respectively)
and subjected to hyperosmotic challenge suppress the upregulation of
AVP content in MNCs in the hypothalamic PVN and SON. Densitometry
results suggested uniform depletion of AVP content in the neuroendo-
crine cells of these nuclei compared to Hyper groups (Fig. 1D, H; Fig.
3D, H), since almost all neurons in MNCs of the PVN and the SON of
Hyper + A1254 and Hyper + DE-71 animals showed poor immunore-
active intensity. The reduced upregulation of AVP content may occur
as a result of exaggerated axonal AVP release secondary to a decrease
in central AVP release caused by perinatal exposure to A1254 and DE-71 (Coburn et al., 2007, 2005). This could lead to deplete AVP stores in
the hypothalamic PVN and SON and activate the synthetic machinery
in the hypothalamicMNCnuclei. These stores are needed during osmot-
ic stress and the carrying storage capacity of the system affects osmo-
regulation (Amaya et al., 1999; Shoji et al., 1994). SD rats perinatally
exposed to A1254 displayed similar physiology to Wistar rats. In this
sense there was no surprise to ﬁnd similar results even when using an
acute hyperosmotic challenge (Fig. 2). This suggest a fast and more di-
rect effect on transcription and/or translation of AVP and a permanent
deﬁcit in the neuroendocrine functions of MNCs both in Wistar and
Sprague-Dawley rats.
In the control normosmotic group, AVP-IR in ﬁbers and cell bodies
showed basal staining similar to that found by other authors using the
same antibody (Ben-Barak et al., 1985; Whitnall and Gainer, 1985;
Whitnall et al., 1985). However, normosmotic rats exposed to either
A1254 or DE-71 showed increased AVP-IR, which was statistically sig-
niﬁcant in the PVN of A1254-exposed and the SON of DE-71-exposed
males (Figs. 1B, a, and 3F, b). The normosmotic rats perinatally exposed
to A1254 showed a non-signiﬁcant increase (7%) in the osmolality
values (Table 2), a signiﬁcant increase in immunoreactivity (Fig. 1Ba),
and a similar trend in the number of AVP-IR neurons (Fig. 4B). Similarly,
under basal normosmotic conditions, DE-71-treated male rats showed
elevated AVP-IR in the SON (Fig. 3F, b; Fig. 4D) in conjunction with nor-
mal plasmaosmolality (Table 2). However, normosmotic A1254-treated
male rats displayed elevated plasma osmolality without showing re-
duced AVP-IR, a result that may be explained by negative effects of
A1254 on kidney function that can impact osmoregulation (Esteban et
al., 2014). In combination, these results indicate a disrupted AVP system
under basal normosmotic conditions.
In the groups of exposed and subjected to the hyperosmotic chal-
lenge rats (Hyper + A1254 and Hyper + DE-71) the osmolality values
were the greatest, indicating that bodywater balancewas compromised
and, hence, osmoregulation was affected (Table 2). These groups also
showed the lowest AVP-IR densities indicating that their deﬁcient os-
moregulation may be due to disregulated AVP signaling (Coburn et al.,
2005; Shah et al., 2011). The effects of organohalogen contamination
may have signiﬁcant consequences for physiological homeostasis de-
pendent on AVP. We and others have previously shown that PCBs and
PBDEs affect thyroid hormones, alter osmoregulation and cardiovascu-
lar parameters and damage kidney function (Albina et al., 2010;
Brouwer et al., 1998; Kodavanti and Curras-Collazo, 2010; Li et al.,
Fig. 6. Effects of perinatal exposure to A1254 on AVPmRNAexpression in PVN and SON ofmale and femaleWistar rats.mRNAswere detected using in situ hybridizationwith [35S]-labeled
probes. LEFT. Dark-ﬁeld representative images frommale rats of PVN and SON coronal sections showAVPmRNA in the PVN and SON in control, A1254, Hyper, andHyper+A1254 groups.
In the Hyper group, AVPmRNA increased both in the PVN and the SON as compared to control (C and G). In contrast, a decrease in the AVPmRNA of neurons occurred after hyperosmotic
stimulation in the Hyper + A1254 as compared to Hyper. RIGHT: The graphs show the IOD of ISHH of AVP mRNA in the PVN (a) and the SON (b). The ANOVA from PVN indicated no
statistically signiﬁcant differences between sexes but there was interaction between sex and treatment groups. In the SON there were no signiﬁcant differences between sexes and no
interactions between sex and treatment. This is the reason that it is depicted as a single group. In the PVN and SON the comparison of control and A1254-exposed rats revealed no
signiﬁcant differences. However, A1254 treatment blunted AVP mRNA levels in animals subjected to prolonged hyperosmotic challenge, although some clusters with high signal
intensity remained in the PVN and SON. When compared with the Hyper group, the AVP mRNA values for Hyper+A1254 decreased signiﬁcantly in the PVN and SON. The bars
represent mean ± s.e.m. values. Statistical signiﬁcance was determined by two-way ANOVA and Holm-Sidak post-hoc test. The symbols represent statistical signiﬁcance, asterisks (*)
compared to control, number symbols (#) compared to Hyper, daggers (†) compared to the other sex (††p b 0.01, ⁎⁎⁎, ###p b 0.001). Abbreviations: third ventricle (3V); optic chiasm
(OX). Calibration bar = 100 μm.
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that perinatal exposure to DE-71 leads to hyperactive cardiovascular re-
sponses to osmotic stress, whichmaybe associatedwith disrupted AVP-
mediated processes and/or kidney function (Shah et al., 2011). Hypo-
thyroid agents like PCBs or PBDEsmay alter AVP secretion and osmoreg-
ulation indirectly by dysregulating thyroid hormone status (Kodavanti
and Curras-Collazo, 2010). Ali et al. (1985) showed that in salt-loaded
rats with induced hypothyroidism, antidiuresis is affected by reducing
AVP-binding sites in the kidneys (Ali et al., 1987, 1985). In the PVN
and SONhypothyroidismprevents osmotically-stimulated upregulation
of transcripts for nitric oxide synthase (NOS), which is required for AVP
functions (Ueta et al., 1995). Related to this our group has shownpersis-
tent reduction of NOS activity in the osmotically activated MNC system
after similar developmental exposure to A1254 (Coburn et al., 2015;
Leon-Olea et al., 2004;Mucio-Ramírez et al., 2008).Moreover, A1254 af-
fects the expression of aquaporin 1 (AQP1) water channels (Tewari et
al., 2009),which are regulated and linked to AVP V2 receptors and nitric
oxide synthase (NOS) involved in water reabsorption (Klokkers et al.,
2009; Swenson et al., 1997); deﬁciencies in the latter has been shown
to impair water retention (Ma et al., 1998).
4.2. Cell count analysis of AVP-IR and Nissl-stained neurons does not indi-
cate MNC cell death of AVP neurons by A1254
In accordance with signiﬁcant reduction of mean AVP-IR IOD in
hyperosmotic groups treated with organohalogens, cell counts of AVP-
IR neurons showed signiﬁcant decreases in the number of positive neu-
rons compared to the Hyper group in PVN and SON (p b 0.001 both; Fig.
4A, B, C, D). Exposure to PCBs and PBDEs has been reported to induce a
concentration-dependent loss of cell viability and apoptosis (Bradner et
al., 2013; Costa et al., 2015; Johansson et al., 2006; Sanchez-Alonso et al.,
2004). Therefore, to determine whether diminished upregulation of
AVP-IR in Hyper + A1254 and Hyper + DE-71 was possibly linked to
MNC cell death, we counted and the total number of cells in Nissl stained
neurons in the medial part of PVN and the SON of all groups. A compari-
son of the total number of Nissl-stained cells in control and A1254-ex-
posed rats did not show a signiﬁcant difference in adult rats (Fig. 4E, F).
Nor did cresyl violet staining show apparent morphological damage in
the PVN and the SON. This suggests that the neurotoxic effect of A1254
on AVP-IR was not due to cell death at these ages. This does not preclude
that organohalogens may produce adverse morphological changes early
in development that may be reversed and undetected in adulthood. For
example, our group has demonstrated neuronal shrinkage, nuclear
pyknosis, and cellular death in nitrergic neurons within MNC nuclei
from A1254-treated male rats at PN10 (Coburn et al., 2015; Leon-Olea
et al., 2004). Cell death was likely to have occurred at early development
stages or during treatment. These changes were short-lived and not ob-
served in adult rats under basal conditions. Transient effects on the num-
ber of mature neurons, in the hippocampal dentate gyrus, have been
reported after developmental exposure to decabrominated PBDEs in
rats on PN20 (Saegusa et al., 2012). As expected, hyperosmotic (Hyper)
groups showed a physiological increase in AVP-IR neurons in PVN
magnocellular andparvocellular regions andSON(Amaya et al., 1999). In-
terestingly, exposure to DE-71 alone led to a signiﬁcant increase in the
number of AVP-IR neurons in the SONof adultmale rats (Fig. 4D). In com-
bination, these data suggest that the decrease in AVP-IR in the
hyperosmotic/treated adult groups were not due to cell death but due
to depletion in AVP content. More reﬁned studies would be required to
know which mechanisms are involved in these changes.
4.3. Hyperosmotic challenge and A1254 exposure activates cFOS gene in
PVN and SON neurons
To explore if reduced AVP content during prolonged hyperosmotic
stress in A1254-exposed rats may be due to vasopressinergic cells not
receiving sufﬁcient activation signals from osmotic stimuli, weperformed end point RT-PCR for cFOS mRNA. The results showed that
Hyper + A1254 group had a marked increase in cFOS mRNA in the
PVN and SON of males and females (Fig. 5). Therefore, upregulated
cFOS mRNA transcript levels correlated well with the rise in plasma os-
molality. However, AVP-IR did not parallel the upregulation seen in
cFOS mRNA levels. Although the micropunches of PVN and SON have
other types of neurosecretory cells, not only vasopressinergic neurons,
the results suggest that in general the osmotic challenge induced an in-
crease in cFOS reaction that is positive in the activation of the system.
Nevertheless this activation was not enough to maintain the AVP pro-
tein levels in the nuclei. This could be due to disrupted AVP synthesis
which may result, in part, from reduced somatodendritic AVP (Coburn
et al., 2007, 2005), that provides local autoregulatory signals (Wotjak
et al., 1994). As expected, the salt-loading induced an increase in cFOS
mRNA levels in the PVN and SON of male and female control groups
(Fig. 5; Leng et al., 1999). This correlates with AVP immunoreactivity
and plasma osmolality increase, as discussed above. Interestingly, the
euhydrated rats exposed to A1254 also showed increase cFOS tendency
in the PVN but not in the SON. Under these experimentally
unstimulated conditions, plasma osmolality was abnormally elevated
as compared to euhydrated rats (Table 2) and the upregulated c-FOS
mRNA levels were consistent with elevated AVP-IR. The speciﬁc effect
on PVNand the abnormal rise in plasma osmolality under “basal” condi-
tions could suggest the involvement of altered renal signalsmediated by
autonomic nerves or kidney damage. Alternatively, A1254 may have a
more focused effect on AVP transcription (but see below), translation
or degradation that is only effective in the absence of hyperosmotic ac-
tivation. For these experiments we normalized the values with the 18S
rRNA gene since it was themost stable gene (Fig. 5A, B).We also probed
several reference genes that were tested to normalize the results: actin,
G3PDH and cyclophilin. These genes showed changes in their levels
under chronic activation (data not shown), which suggested a general
systemic damage due to exposure to these organohalogens.
4.4. Perinatal exposure to A1254 suppresses the physiological increase of
AVP mRNA levels in the PVN and SON during chronic hyperosmotic stress
Previous studies have shown that repeated osmotic stimulation in-
duces a compensatory increase in AVP mRNA levels and peptide pro-
duction within the PVN and SON (Amaya et al., 1999; Meister et al.,
1990). To explore if reduced AVP content during chronic hyperosmotic
stress in A1254-exposed rats may be due to disrupted gene expression,
we performed in situ hybridization histochemistry for AVPmRNA.Mea-
surement of AVP mRNA levels (expressed as the density of developed
silver grains) showed a physiologically activated increase in the PVN
and the SON of salt-loaded males and females, compared to their con-
trols (Fig. 6C, G), a ﬁnding that has been previously reported by several
authors (Amaya et al., 1999; Meister et al., 1990). In contrast, in the
Hyper + A1254-exposed groups, there were no expected physiological
increases in AVP mRNA levels—hence, no differences from their control
groups for nucleus or sex (Fig. 6D, Ha, b). Instead, therewas a signiﬁcant
decrease inmeanAVPmRNAcompared to theHyper groups, correlating
with the lack of upregulated AVP-IR on this group. For the A1254-ex-
posed normosmotic groups there were no signiﬁcant differences in
meanAVPmRNA IODvalues as compared to the control groups, indicat-
ing a lack of induction of AVP mRNA in response to elevated cFOS and
plasma osmolality seen in this group (especially males). It is unclear
how the disconnection between c-FOS and AVP mRNA occurs in the
A1254 groups but it may involve changes in NOS. For example, NOS iso-
forms such as inducible NOSmay negatively regulate AVP gene expres-
sion (Oliveira-Pelegrin et al., 2010). However, A1254 may still induce
themarkedly elevated AVP-IR discussed above through downstreamef-
fects on neuronal NOS. For example, a recent study by our group
showed that in utero exposure to A1254 alone produces abnormally el-
evated neuronal NOS activity in adult rats as measured by NADPH-di-
aphorase staining in ﬁxed brain tissue (Coburn et al., 2015). Our lab
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(Gillard et al., 2007; Kadowaki et al., 1994).
In conclusion, both PCBs and PBDEs disrupt basal and stimulated
AVP responses inMNCnuclei. AlthoughPVNand SON in exposed groups
were activated in response to the hyperosmotic stimulus (increased
cFOS), neither the rapid translation of cFOS nor AVPmRNAwas enough
to restore AVP content in the PVN and SON, during hyperosmotic condi-
tions. Nor was it enough to regulate plasma osmolality, as evidenced by
the fact that the highest values (p b 0.001) were in the Hyper treated
groups especially in Hyper + A1254 group (Table 2). This could lead
to serious disturbances in homeostasis. A1254 treatment alone resulted
in activation of c-FOSmRNA in PVN and AVP-IRwithout upregulation of
AVP mRNA. The mechanisms underlying these effects are unclear but
may be related to the effects of PCBs on NOS which can affect AVP sys-
tem at transcription and secretion levels. Other mechanisms that may
have intervened to decrease AVP content during chronic osmotic stress
in A1254- and DE-71-exposed rats may be disrupted downstream syn-
thetic mechanisms. A possible mechanism may have been that dioxin-
like organohalogens activate the aryl hydrocarbon receptor (AhR;
Denison and Nagy, 2003; Kodavanti and Curras-Collazo, 2010). After li-
gand binding, a heterodimer is formed which translocates into the nu-
cleus and links to speciﬁc DNA regions. This, in turn, regulates
transcription velocity of speciﬁc genes and produces genetic alterations
that modify processes and functions in the cell (Denison and Nagy,
2003; Safe et al., 1985; Tilson et al., 1998), which could partially explain
the unbalanced effects on AVP mRNA and content reported here.
Further research is warranted to identify the mechanisms involved
in the disruption of the AVP system by organohalogens, since the AVP
system is one of the main systems necessary to maintain hydromineral
homeostasis that can impact osmoregulation, cardiovascular function
and central AVP-regulated behavior.
5. Conclusions
Perinatal exposure to either A1254 or DE-71 affects the AVP system
similarly in males and females; this effect was more evident during the
hyperosmotic challenge although signiﬁcant effects were detected
under basal conditions. Exposure dramatically reduces
hyperosmotically stimulated responses in AVP content and mRNA ex-
pression of MNCs in the PVN and the SON. These PCBs and PBDEs
seem to produce similar disruption of neuroendocrine processes. The
physiological outcome of the lack of response to increment AVP content
inMNCduringhyperosmotic stress in A1254- or DE-71-exposed rats led
to a rise in plasma osmolality, an indication of disruptedwater and elec-
trolyte balance.
Vasopressin not only participates in endocrine regulation of body
ﬂuid and cardiovascular function, but also regions such as the hypothal-
amus, amygdala, and hippocampus are known to contain either AVP
neurons or terminals and play a role in cognitive functions and regulat-
ing complex social behaviors (Shou et al., 2017; Stoop, 2012). Our ﬁnd-
ings of AVP system disruption highlight the possibility that these
organohalogens may affect those other AVP brain functions (Messer,
2010; Shou et al., 2017). More reﬁned studies would be required to as-
sess impacts on these functions. In addition, the high body burdens of
PCBs and PBDEs in children are of particular concern. Environmental
organohalogens should, therefore, be considered a public health threat
that must be addressed.
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